Early research (Phase 1)WithdrawnNCT04972253What this trial is testingPhase I BLASST-3 TrialWho this might be right forBladder Transitional Cell CarcinomaBladder CancerFibroblast Growth Factor Receptor Guru P. Sonpavde
Testing effectiveness (Phase 2)Study completedNCT00066612What this trial is testingS0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 45
Testing effectiveness (Phase 2)Study completedNCT01616875What this trial is testingBristol Bladder TrialWho this might be right forInfiltrating Bladder Urothelial Carcinoma University Hospitals Bristol and Weston NHS Foundation Trust 28
Large-scale testing (Phase 3)Study completedNCT00315237What this trial is testingPhase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial TractWho this might be right forTransitional Cell Carcinoma of the Urothelial TractBladder CancerBladder Neoplasms Pierre Fabre Medicament 364
Early research (Phase 1)Enrolling By InvitationNCT07353294What this trial is testingPropranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UCWho this might be right forBladder Urothelial CarcinomaLymph Node Metastasis Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 12
Not applicableUnknownNCT05276167What this trial is testingHyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial CarcinomaWho this might be right forHigh-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications Henan Cancer Hospital 40
Not applicableStudy completedNCT06505746What this trial is testingReal-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi ArabiaWho this might be right forMetastatic Urothelial Cancer Astellas Pharma Singapore Pte. Ltd. 287
Not applicableLooking for participantsNCT06167356What this trial is testingStudy on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.Who this might be right forNon Muscle Invasive Bladder CancerNon-Muscle Invasive Bladder NeoplasmsNon-Muscle Invasive Bladder Urothelial Carcinoma+8 more IRCCS San Raffaele 20,000
Not applicableNot Yet RecruitingNCT06675656What this trial is testingPredictive Role of Microbiome in Patients With Urothelial CarcinomaWho this might be right forUrinary Bladder Cancer IRCCS San Raffaele 420
Early research (Phase 1)Study completedNCT02318329What this trial is testingOpen-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGastric CancerTransitional Cell Carcinoma of the Bladder Five Prime Therapeutics, Inc. 79
Early research (Phase 1)Study completedNCT00536588What this trial is testingA Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816)Who this might be right forBladder Neoplasms Merck Sharp & Dohme LLC 17
Large-scale testing (Phase 3)Ended earlyNCT00384891What this trial is testingHyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerWho this might be right forUrinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more Medical Enterprises Europe B.V. 190
Not applicableStudy completedNCT06607250What this trial is testingBp-MRI Based Multi-planar VI-RADSWho this might be right forBladder (Urothelial, Transitional Cell) CancerMRI The First Affiliated Hospital with Nanjing Medical University 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT05535218What this trial is testingPembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder CancerWho this might be right forMuscle-invasive Urothelial Carcinoma of the Bladder Claudia Guerrieri 48
Early research (Phase 1)WithdrawnNCT05259397What this trial is testingPF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)Who this might be right forBladder Cancer Pfizer
Testing effectiveness (Phase 2)UnknownNCT02278978What this trial is testingBIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial CarcinomaWho this might be right forUrothelial Carcinoma National Taiwan University Hospital 129
Testing effectiveness (Phase 2)Ended earlyNCT01215136What this trial is testingFirst-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial CarcinomaWho this might be right forTransitional Cell CarcinomaBladder CarcinomaUrothelial Carcinoma Matthew Galsky 36
Not applicableLooking for participantsNCT06818136What this trial is testingBladder EpiCheck European Haematuria StudyWho this might be right forHematuriaCystoscopyUrothelial Carcinoma Bladder+2 more Nucleix Ltd. 800
Testing effectiveness (Phase 2)Study completedNCT01824329What this trial is testingProstate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder CancerWho this might be right forBladder CancerTransitional Cell Carcinoma of the Bladder University of Michigan 40
Not applicableLooking for participantsNCT07080333What this trial is testingMICROBIOTA AND BLADDER CANCERWho this might be right forBladder (Urothelial, Transitional Cell) Cancer Centre Hospitalier Universitaire de Nice 95